Robeco Institutional Asset Management B.V. trimmed its holdings in Dolby Laboratories (NYSE:DLB – Free Report) by 9.5% in the third quarter, HoldingsChannel reports. The fund owned 165,577 shares of the electronics maker’s stock after selling 17,302 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Dolby Laboratories were worth $11,983,000 at the end of the most recent quarter.
A number of other institutional investors also recently made changes to their positions in the business. Boothbay Fund Management LLC raised its position in Dolby Laboratories by 4.1% in the 2nd quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock worth $299,000 after purchasing an additional 157 shares during the period. Mitchell & Pahl Private Wealth LLC grew its stake in shares of Dolby Laboratories by 1.1% during the third quarter. Mitchell & Pahl Private Wealth LLC now owns 15,733 shares of the electronics maker’s stock valued at $1,139,000 after buying an additional 170 shares during the last quarter. Equitable Trust Co. grew its stake in shares of Dolby Laboratories by 3.3% during the second quarter. Equitable Trust Co. now owns 5,567 shares of the electronics maker’s stock valued at $413,000 after buying an additional 177 shares during the last quarter. Steward Partners Investment Advisory LLC increased its holdings in shares of Dolby Laboratories by 13.9% in the second quarter. Steward Partners Investment Advisory LLC now owns 1,587 shares of the electronics maker’s stock worth $118,000 after buying an additional 194 shares during the period. Finally, State of Michigan Retirement System lifted its stake in shares of Dolby Laboratories by 1.4% in the 2nd quarter. State of Michigan Retirement System now owns 14,800 shares of the electronics maker’s stock valued at $1,099,000 after acquiring an additional 200 shares during the last quarter. Hedge funds and other institutional investors own 58.56% of the company’s stock.
Dolby Laboratories Stock Performance
NYSE DLB opened at $63.62 on Friday. The stock has a market cap of $6.08 billion, a P/E ratio of 24.19 and a beta of 0.88. Dolby Laboratories has a fifty-two week low of $63.14 and a fifty-two week high of $89.66. The stock has a 50 day simple moving average of $65.99 and a two-hundred day simple moving average of $70.23.
Dolby Laboratories Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, December 10th. Stockholders of record on Tuesday, December 2nd were given a $0.36 dividend. The ex-dividend date of this dividend was Tuesday, December 2nd. This represents a $1.44 annualized dividend and a dividend yield of 2.3%. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. Dolby Laboratories’s dividend payout ratio is 54.75%.
Insider Activity at Dolby Laboratories
In related news, SVP John D. Couling sold 7,273 shares of the business’s stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $68.75, for a total transaction of $500,018.75. Following the transaction, the senior vice president owned 108,065 shares in the company, valued at $7,429,468.75. The trade was a 6.31% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Mark Andrew Sherman sold 2,491 shares of the stock in a transaction dated Wednesday, December 17th. The stock was sold at an average price of $67.26, for a total transaction of $167,544.66. Following the completion of the transaction, the executive vice president directly owned 70,563 shares of the company’s stock, valued at approximately $4,746,067.38. The trade was a 3.41% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 162,120 shares of company stock worth $10,906,559. 37.93% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
Several equities analysts recently issued reports on the company. Rosenblatt Securities reduced their price target on Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating on the stock in a research report on Wednesday, November 19th. Barrington Research dropped their price objective on Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating for the company in a research note on Wednesday, November 19th. Wall Street Zen upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Monday. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Monday, December 29th. Three equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, Dolby Laboratories currently has an average rating of “Moderate Buy” and an average target price of $92.00.
View Our Latest Report on Dolby Laboratories
About Dolby Laboratories
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Read More
- Five stocks we like better than Dolby Laboratories
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- First Time Since 2007: All Warnings Active
- Executive Order 14330: Trump’s Biggest Yet
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
